Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.

NCT00219024 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2775
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis